MedTrace Logo

Sleep Apnea Treatment After Stroke (SATS)

NCT00282815 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2013-03-11

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine if treating stroke patients who have obstructive sleep apnea with continuous positive airway pressure will improve symptoms caused by the stroke.

Conditions

Interventions

DEVICE

continuous positive airway pressure or CPAP

RemStar Pro (Respironics, Inc.) The CPAP is applied through a nasal mask during the hours of sleep. Positive air pressure holds the naso-oro-pharyngeal airway open during sleep.

DEVICE

sham CPAP

sham CPAP

Sponsors & Collaborators

Principal Investigators

  • Devin Brown, MD, MS · Associate Professor, Stroke Program, University of Michigan

  • Lewis Morgenstern, MD · Director, Stroke Program, University of Michigan

  • Jack Kalbfleisch, PhD · University of Michigan Dept of Biostatistics

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-09-30
Primary Completion
2010-05-31
Completion
2010-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00282815 on ClinicalTrials.gov